Tech Company Financing Transactions
Deep Apple Therapeutics Funding Round
Deep Apple Therapeutics closed a $52 million Series A venture capital round on 12/15/2023. Backers included Apple Tree Partners.
Transaction Overview
Company Name
Announced On
12/15/2023
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series A
Investors
Apple Tree Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
230 Park Ave 2800
New York, NY 10169
USA
New York, NY 10169
USA
Phone
Undisclosed
Website
Email Address
Overview
Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor ß (ERß). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carol Curtis
Chief Operating Officer
Elaine Hamm
Browse more venture capital transactions:
Prev: 12/15/2023: Spotta venture capital transaction
Next: 12/15/2023: Tempello venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs